Cancer trials support unit (ctsu) IDIQ
Active Awarded Last action
- Contract number
- 75N91022D00015
- Awardee
-
Essex Management LLC UEI W43LZWHV2853
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Task orders
- 0
Award facts
- Opportunity
-
- Cancer Trials Support Unit Pre-Solicitation · 75N91021R00021 · Posted Sep 10, 2021
- Last date to order 85% complete
- IDV ceiling
- $548,000,000.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 8 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Cancer Institute awarded a multiple-award indefinite-delivery contract to Essex Management LLC with a $548 million ceiling on August 1, 2022, to provide operational, regulatory, and IT support to multi-institutional cancer trials led by NCI-supported clinical trial organizations. Task areas three, five, and six are partially set aside for small businesses; Essex competes unrestricted across all task areas. The contract runs through July 31, 2027.
Place of performance centers in the Bethesda and Westlake, Maryland biomedical research corridor and spans multi-institutional cancer trials nationally and internationally. The solicitation, posted September 10, 2021 with proposals due October 1, 2021, sought demonstrated experience in oncology clinical research, clinical trial operations, and information technology systems across six task areas. NAICS codes 541715 and 541712 and PSC codes R425 and R499 apply. The base contract for task area two was awarded to a single contractor; multiple contractors received awards for task areas three through six.
Essex performs operational, regulatory, and IT support functions including health informatics systems, biomedical data integration, clinical trial reporting platforms, and cancer surveillance registries. The vendor operates as a subsidiary of The Emmes Company, LLC and concentrates its federal portfolio on the National Cancer Institute, with the agency accounting for 11 of 16 prime awards across its footprint. Essex performs on time-and-materials and labor-hours delivery orders, with government-paid hourly rates at a median of $138.36 per hour and senior labor pricing to $174.71 per hour at the 90th percentile across SCI-reportable contracts.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N91022D00015?
75N91022D00015 was awarded to Essex Management LLC by National Cancer Institute (National Institutes of Health) on August 1, 2022.
How much is contract 75N91022D00015 worth?
75N91022D00015's own ceiling is $548,000,000.
Who can order from contract 75N91022D00015?
75N91022D00015 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract 75N91022D00015 part of a contract vehicle?
Yes. 75N91022D00015 is part of Cancer Trials Support Unit.
Was contract 75N91022D00015 competed?
The extent of competition for 75N91022D00015 was full and open competition. The government received 8 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV